Drug intelligence / Profile preview

Investigational Facial Serum #2

Development stage: Preclinical
Lead developer: Victoria Collotta
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Investigational Facial Serum #2 is a topical preparation designed to improve the signs of aging. It contains an unspecified active comparator and is currently undergoing clinical evaluation to assess its efficacy in addressing facial fine lines and wrinkles, including crow's feet. The product is being developed under the sponsorship of Victoria Collotta.

Beyond the preview

Go deeper on Investigational Facial Serum #2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Investigational Facial Serum #2.

Explore the full profile